发明名称 新規なニコチンアミド誘導体またはその塩
摘要 <p>An object of the present invention is to provide to a compound and a pharmaceutical composition, which have excellent Syk-inhibitory activity. Th e present invention provides a nicotinamide derivative represented by the follo wing formula (I) (wherein R 1 represents a halogen atom; R 2 represents a C 1-12 alkyl group, a C 2-12 alkenyl group, a C 2-12 alkynyl group, a C 3-8 cycloalkyl g roup, an aryl group, an ar-C 1-6 alkyl group or a heterocyclic group, each opti onally having at least one substituent; R 3 represents an aryl group or a hetero cyclic group each optionally having at least one substituent; and R 4 and R 5 e ach independently represent a hydrogen atom; and R 2 and R 4 may form a cyc lic amino group optionally having at least one substituent together with the ni trogen atom to which they bind) or a salt thereof, and a pharmaceutical comp osition for use in the treatment of a Syk-related disease which comprises the nicotinamide derivative or a salt thereof.</p>
申请公布号 JP5744021(B2) 申请公布日期 2015.07.01
申请号 JP20120522731 申请日期 2011.06.30
申请人 发明人
分类号 C07D213/82;A61K31/44;A61K31/443;A61K31/4439;A61K31/444;A61K31/4545;A61K31/4709;A61K31/496;A61K31/498;A61K31/4985;A61K31/506;A61K31/517;A61K31/5377;A61K31/5383;A61P7/00;A61P29/00;A61P37/00;A61P43/00;C07D215/40;C07D401/04;C07D401/12;C07D401/14;C07D405/14;C07D409/12;C07D409/14;C07D413/12;C07D413/14;C07D417/12;C07D417/14;C07D471/04;C07D491/048;C07D491/056;C07D491/107;C07D498/04;C07D513/04 主分类号 C07D213/82
代理机构 代理人
主权项
地址